|
Originally published In Press as doi:10.1074/jbc.M111862200 on April 24, 2002
J. Biol. Chem., Vol. 277, Issue 27, 24653-24658, July 5, 2002
A "Minimal" Sodium Channel Construct Consisting
of Ligated S5-P-S6 Segments Forms a Toxin-activatable
Ionophore*
Zhenhui
Chen ,
Carmen
Alcayaga§,
Benjamin A.
Suárez-Isla§,
Brian
O'Rourke,
Gordon
Tomaselli, and
Eduardo
Marbán¶
From the Institute of Molecular Cardiobiology, The Johns Hopkins
University School of Medicine, Baltimore, Maryland, 21205 and the
§ Program of Physiology and Biophysics, Institute of
Biomedical Sciences, Faculty of Medicine, University of Chile,
Santiago 6530499, Chile
Received for publication, December 12, 2001, and in revised form, March 29, 2002
 |
ABSTRACT |
The large size (six membrane-spanning repeats in
each of four domains) and asymmetric architecture of the
voltage-dependent Na+ channel has
hindered determination of its structure. With the goal of determining
the minimum structure of the Na+ channel permeation
pathway, we created two stable cell lines expressing the
voltage-dependent rat skeletal muscle Na+
channel (µ1) with a polyhistidine tag on the C terminus (µHis) and
pore-only µ1 (µPore) channels with S1-S4 in all domains removed. Both constructs were recognized by a Na+ channel-specific
antibody on a Western blot. µHis channels exhibited the same
functional properties as wild-type µ1. In contrast, µPore channels
did not conduct Na+ currents nor did they bind
[3H]saxitoxin. Veratridine caused 40 and 54% cell
death in µHis- and µPore-expressing cells, respectively. However,
veratridine-induced cell death could only be blocked by tetrodotoxin in
cells expressing µHis, but not µPore. Furthermore, using a
fluorescent Na+ indicator, we measured changes in
intracellular Na+ induced by veratridine and a
brevotoxin analogue, pumiliotoxin. When calibrated to the
maximum signal after addition of gramicidin, the maximal percent
increases in fluorescence ( F) were 35 and 31% in cells
expressing µHis and µPore, respectively. Moreover, in the presence
of 1 µM tetrodotoxin, F decreased
significantly to 10% in µHis- but not in µPore-expressing cells
(43%). In conclusion, S5-P-S6 segments of µ1 channels form a
toxin-activable ionophore but do not reconstitute the Na+
channel permeation pathway with full fidelity.
 |
INTRODUCTION |
Sodium channels conduct the electrical impulse in excitable
tissues and serve as the receptors for many drugs and toxins (1). Their
essential functional features include highly selective permeation of
Na+ and voltage-dependent gating (2-5). The
principal functional unit of the Na+ channel is the subunit, which consists of four internally homologous domains (labeled
DI-DIV),1
each containing six transmembrane segments (S1-S6) and resembling a
single subunit of a voltage-dependent K+
channel (6) (Fig. 1A). These four homologous domains are
pseudosymmetrically arranged around a central pore whose structural
constituents determine the selectivity and conductance properties of
the channel. While the fourth transmembrane segment S4, studded with
positively charged residues, confers voltage-sensitive gating (7), the
S5 and S6 segments and the S5-S6 linker or the pore-lining ("P")
segment line the permeation pathway. Such a structure, while complex
and asymmetrical, hints that essential features of the pore may be separable from those that confer gating.
MacKinnon and coworkers (8) have solved the crystal structure of an
inwardly rectifying bacterial K+ channel (KcsA) channel.
This important advance provides a framework for testing hypotheses
concerning the pore structure of related channels. With only two
transmembrane segments and a P segment in each subunit, KcsA channels
function perfectly well as K+-selective ionophores.
Compared with KcsA and other Kir-like channels, voltage-dependent channels, sharing the same transmembrane
topology of the core segments, have evolved four additional
transmembrane segments (S1-S4) in each domain with S4
responsible for voltage gating and S1-S3 presumably insulating
hydrophilic S4 from the lipid bilayer. In this view, the functional
pore might be fully encoded by the S5-P-S6 fragments, while the rest of
the protein is required only for effecting
voltage-dependent conformational changes (Fig.
1B). Therefore, it is logical to ask whether a
Na+ channel comprised only of S5-P-S6 from each domain will
contain the minimal determinants of a functional pore.
In this study, we stably expressed poly(His)-tagged wild-type and
pore-only µ1 channel constructs in mammalian cell lines and
characterized them biophysically, biochemically, and functionally. The
main goal was to test whether the pore-only µ1 channel is functional
as an ionophore and as a high affinity toxin-binding scaffold. Such a
reduced construct, if functional, would simplify structural
determination of the pore region.
 |
EXPERIMENTAL PROCEDURES |
Materials and Chemicals--
Materials were from the following
sources. Saxitoxin (STX) dihydrochloride was kindly provided by
Dr. Sherwood Hall (Federal Drug Administration);
[3H]STX was from Amersham Biosciences;
N-methyl-D-glucamine, veratridine, and
tetrodotoxin (TTX) were obtained from Sigma; PbTx-3 (pumiliotoxin) was
from Calbiochem; HEK293 cells were from the American Type Culture
Collection (Manassas, VA); CoroNa Red sodium indicator and gramicidin A
were from Molecular Probes (Eugene, OR); anti-Na+ channel
antibody was purchased from Upstate Biotechnology (Lake Placid, NY);
and Geneticin (G418 Sulfate) was from Invitrogen.
Molecular Biology--
A DNA fragment containing a c-Myc
epitope and a polyhistidine tag from pCDNA3.1 (Invitrogen) was
inserted into the XbaI site at the 3'-end of the skeletal
muscle Na+ channel (µ1) to generate µ1 His-tagged DNA
(µHis). µHis DNA, coupled with a green fluorescent protein reporter
gene, was then cloned in a polycistronic IRES vector, allowing
independent translation of two separate proteins from a single
mRNA. The pore-only µ1 DNA (µPore) was generated by deleting
S1-S4 of each domain (Fig. 1, A and C).
Specifically, Leu128-Lys228 in domain
I, Leu567-Leu680 in domain
II, Ile1020-Glu1137 in domain
III, and Phe1342-Leu1465 in domain
IV were deleted by PCR using primers with bases covering regions adjacent to the sections of the channel that were deleted (Stratagene). All constructs were verified by sequencing. For mRNA
generation, these constructs were cloned into pSP64T vector, and
mRNA was transcribed from the SP6 promoter (Ambion, Inc.)
Cell Biology--
All cells were grown in Dulbecco's modified
Eagle's medium with 10% (v/v) fetal calf serum, 100 units/ml
penicillin, 0.1 mg/ml streptomycin at 37 °C with 5%
CO2. Linearized DNA of µHis and µPore were transfected
into HEK293 cells, respectively, using LipofectAMINE Plus Reagent
(Invitrogen). Two days after transfection, cells were serially diluted
with the addition of 0.5 mg/ml Geneticin to select for transfected
cells. Colonies were screened initially by epifluorescence and further
characterized by whole-cell current measurements and Western blot
analysis. Positive clones were again sorted by green fluorescent
protein signals using a FACStar Plus cell sorter. For functional
assays, 0.5 million cells were seeded and grown overnight in a 35-mm
dish. Veratridine was first dissolved in ethanol at a concentration of
150 mM and then in culture medium. For blocking
experiments, cells were incubated with TTX for 1 h before adding
veratridine. Cell death was determined by counting the percentage of
floating cells and trypsinized attached cells that failed to exclude
trypan blue.
Electrophysiology--
Patch clamp and two electrode
voltage-clamp were performed as described previously (9). All
recordings were carried out at room temperature (~21 °C).
Membrane Vesicle Preparation--
Cells were washed with cold
phosphate-buffered saline, pelleted, resuspended in 1 mM
EDTA, 50 mM Tris-Cl (pH = 8.0) with protease inhibitors (Roche Molecular Biochemicals), and homogenized. The homogenate was brought up in a final concentration of 300 mM sucrose, 0.5 mM EDTA, 10 mM
Hepes-Tris (pH = 7.5) and homogenized again before centrifuging at
4,000 × g for 15 min at 4 °C. The supernatant was
retained, and homogenization and centrifugation were repeated on the
pellet. The supernatants were then mixed to a final concentration of
0.6 M KCl. The mixture was stirred gently for 30 min at
4 °C before centrifuging at 100,000 × g for 1 h. The pellet was resuspended in 300 mM sucrose, 10 mM MOPS-Tris (pH = 7.0) and homogenized using a
glass-Teflon homogenizer. Protein concentration was determined by a
Lowry assay (10). For rat brain membrane vesicle preparation, rat
brains were immersed in cold 20 mM MOPS-Tris (pH = 7.4), homogenized using a glass-Teflon homogenizer, and then subjected
to the previously described cell membrane vesicle isolation protocol.
Normally one rat brain yields about 80 mg of total membrane protein.
STX Binding Assay--
The [3H]STX binding assay
was performed as described previously by Vélez et al.
(11). 250 µg of membrane vesicles were incubated on ice for 1 h
with buffer containing 2.5 nM [3H]STX, 30 mM choline chloride, 10 mM Hepes-Tris, pH 7.4, and a range of cold STX from a concentration of 0 to a maximum of 4 µM in a 250-µl reaction volume. Free
[3H]STX was removed by passing each reaction mixture
through a glass filter. The filter was washed twice and counted using a
scintillation counter.
Fluorescent Indicator Loading and
Microfluorometry--
For optimal dye loading, cells were
incubated with 1 µM CoroNa Red Na+ indicator
(from a freshly dissolved 1 mM stock
Me2SO solution, Molecular Probes) in 140 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 1 mM CaCl2, 10 mM glucose, pH 7.4 at 37 °C for 2 h.
Cells were plated on 15-mm glass coverslips and mounted on a perfusion
chamber (Warner Instruments, PH4) that was placed on the stage of a
Nikon Diaphot inverted fluorescence microscope. A 20× Nikon oil
immersion lens was used, and all experiments were done at room
temperature. The fluorescence cube in the microscope consisted of a
540 ± 15 nm excitation filter, a 565LP dichroic mirror, and a
620 ± 30 nm emission filter. A 12-bit monochrome cooled CCD
camera (5 MHz readout rate, MicroMax, Princeton Instruments) was used
to collect 650 × 514 pixel 16-bit grayscale images once every minute
with either a 100- or 200-ms exposure time.
Experiments were performed during continuous perfusion of buffers and
drugs at 0.6-1.0 ml/min. A run was initiated after a stable
fluorescence signal was obtained during perfusion of control solution
containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM glucose, pH 7.4. At least 10 images were obtained in
each condition. Addition of PbTx-3, an analogue of brevotoxin, and veratridine elicited a slow increase of fluorescence that usually reached steady state within 10-15 min. Normally only one addition of
toxin could be done per run. The chamber was then perfused with control
solution to dilute the added toxin, and the calibration sequence was
initiated. In this case, perfusion was interrupted, and 1 ml of 2 µM gramicidin dissolved in control solution was directly
added to the chamber. After development of maximal fluorescence, typically 6-10 min, perfusion was restarted, and the calibration sequence was completed by the consecutive addition of buffers containing different sodium concentrations.
Data Analysis--
At least five regions of interest covering
all the cells were measured in each experiment. Average fluorescence
intensity of each region of interest was analyzed by ImageJ
(rsb.info.nih.gov/ij/). The percent changes for fluorescence
signal, corresponding to the intracellular Na+ changes,
were calibrated with gramicidin and calculated using the following
formula: (F Fmin)/(Fmax Fmin) × 100%, where F is the
fluorescence signal, Fmin is the control signal
in normal 140 mM Na+ buffer, and
Fmax is the maximum signal in the presence of
gramicidin. At least five points in the plateau were averaged for each
treatment. Data were further analyzed and plotted using Origin
(Microcal Software, Inc.)
 |
RESULTS |
Channel Protein Expression--
We created two HEK293 stable cell
lines expressing either wild-type µ1 channels with a c-Myc epitope
and a polyhistidine (µHis) tag fused to the C terminus or pore-only
µ1 (µPore) channels with S1-S4 in all domains removed (Fig.
1C). The stably transfected cells all had a normal morphology under basal conditions. Membrane vesicles prepared from both cell lines were recognized by a
Na+ channel-specific antibody directed to the retained
III-IV interdomain linker (SP19). µHis channels,
with a calculated molecular mass of 212 kDa, ran at 240 kDa,
while µPore, with a calculated molecular weight of 159 kDa, ran at
210 kDa on a Western blot (Fig. 2). Antibodies raised to the c-Myc and poly(His) tags both recognized µPore and µHis channels (data not shown), indicating that the entire constructs were faithfully expressed. Using a polycistronic IRES vector, we found that the reporter green fluorescent
protein and the channel construct were independently expressed and
co-localized. In cells expressing either µHis or µPore channels,
confocal microscopy indicated that the green fluorescent protein
signals were detected at the cell surface membrane (data not shown).
These results indicated that µPore channels were expressed at the
surface membrane.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic depictions of the Na+
channel subunit. A,
transmembrane topology of the N+ channel. The
boxes enclose the S1-S4 segments that were deleted to
generate the µPore channel. The amino acids of the start of S1 and
the end of S4 in each domain are indicated. B, schematic of
the folding of the Na+ channel around the ion-selective
pore. The ring highlights the putative channel pore-lining
segments. C, transmembrane topology of the µPore
Na+ channel where S1-S4 segments were deleted in all
domains.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 2.
Immunoblot analysis. A Na+
channel-specific antibody that recognizes an epitope in the interdomain
III-IV linker binds to both µPore and µHis
channels. Membrane vesicles were prepared as described under
"Experimental Procedures." 10 µg of total membrane proteins for
µPore, µHis, and HEK293 cells were subjected to SDS-PAGE (4-15%
gradient) and immunoblotting with an anti-Na+ channel
polyclonal antibody.
|
|
Channel Activity--
Channel activity of the µHis and µPore
channels was functionally characterized using the patch clamp
technique. Whole-cell currents from cells stably expressing µHis
channels exhibit the same electrophysiological properties as wild-type
µ1 channels (Fig. 3A),
indicating they are fully functional. In contrast, µPore failed to
conduct measurable time-dependent,
Na+-selective currents despite expression of the protein
(Fig. 3B). In addition, no currents were observed in either
mRNA-injected Xenopus oocytes or transiently transfected
HEK293 cells (data not shown). One explanation is that µPore channels
may not be able to fold properly to form an ionophore; alternatively,
µPore channels may generate a pore that favors a closed conformation. Since the voltage-sensing S4 segments are not present in µPore channels, voltage changes may not be able to generate conformational changes necessary to open µPore channels. Nevertheless, we explored the possibility that such channels might retain toxin sensitivity.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Whole-cell Na+ current
recordings. Shown are currents elicited by a family of
depolarizing voltage steps from a holding potential of 100 mV to test
voltages of 60 to +50 mV in increments of 10 mV. In A,
HEK293 cells expressing µHis channels exhibit normal currents, while
in B, cells expressing µPore channels did not have any
time- or voltage-dependent currents.
|
|
STX Binding Assay--
TTX and STX block the Na+
channels at neurotoxin receptor site 1, which is localized near the
extracellular opening of the pore. High affinity STX binding requires a
highly stereotypical three-dimensional structure with crucial
contributions from numerous pore residues present in the extracellular
linkers, including those from the P segments (12-16). Thus,
preservation of STX binding could be considered as evidence of proper
processing and folding of µPore channels. We performed STX binding
assays on membrane vesicles of rat brain, stable cell lines expressing
µ1 and µPore channels, and non-transfected HEK293 cells. Control
HEK293 cells did not bind STX. In contrast, rat brain membrane vesicles
exhibited strong [3H]STX binding with a total
concentration of the binding sites (Bmax) of
0.86 pmol of [3H]STX binding/mg of total membrane protein
in agreement with previous reports (17, 18). Membrane vesicles
containing µ1 channels exhibited specific [3H]STX
binding with a Bmax of 0.46 pmol/mg of protein
(Fig. 4A). However, the
[3H]STX binding signal of membrane vesicles containing
µPore channels was indistinguishable from background. In addition, in
[3H]STX displacement assays using non-radioactive STX,
rat brain membrane vesicles and membrane vesicles containing µ1
channels exhibited specific [3H]STX binding (Fig.
4B), but again µPore channels did not exhibit any
[3H]STX displacement. These data suggest that µPore
channels did not preserve a Na+ channel structure that
specifically binds to STX. Nevertheless, we tested whether µPore
channels remained sensitive to other Na+ channel toxins
that bound to sites distinct from the STX binding site.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
[3H]STX binding in membrane
vesicles of rat brain, native HEK293 cells, and cells expressing
µ1His and µPore
channels. A, equilibrium binding of 2.5 nM
[3H]STX binding to membrane vesicles as described under
"Experimental Procedures" (n = 3). B,
[3H]STX displacement by increasing concentrations of cold
STX. In contrast to rat brain and µ1His-containing vesicles, µPore
(n = 3) did not exhibit any [3H]STX
displacement.
|
|
Veratridine-induced Cell Death--
Veratridine causes persistent
opening of Na+ channels and elevates intracellular
Na+ concentration, which perturbs ion homeostasis
sufficiently in neurons and astroglia to trigger cell death (19, 20).
If our cells contained any toxin-activable Na+ channels,
they may likewise die during exposure to veratridine. Thus, we
determined whether veratridine affected cell viability in our stable
cell lines.
Control (non-transfected) HEK293 cells and cells expressing µPore and
µHis channels were incubated with various concentrations of
veratridine for 20 h at 37 °C, 5% CO2. Cell death
was assayed by the inability to exclude trypan blue (Fig.
5A). In the absence of
veratridine, none of the three cell lines exhibited measurable cell
death. However, at veratridine concentrations of 200 µM
or higher, cells expressing µHis and µPore channels showed
significantly more cell death than did control HEK293 cells. At 225 µM veratridine, in control HEK293 cells, only 16% of
cells were killed, but 40 and 54% of cells expressing µHis and
µPore channels died, respectively (Fig. 5B). This effect
was specific as the proapoptotic agents staurosporine and etoposide did
not cause more cell death in µPore cells than in µHis cells (data
not shown).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 5.
Veratridine induced cell death.
A, in normal Dulbecco's modified Eagle's medium,
veratridine reduced cell survival in µ1His- and µPore-expressing
HEK293 cells as assessed by failure to exclude trypan blue.
B, veratridine-induced cell death was partial blocked by TTX
in cells expressing µ1His channels but not µPore channels
(n = 4; *, p < 0.01, one-way analysis
of variance).
|
|
When STX/TTX binding is intact, TTX potently blocks the action of site
2 toxins. Therefore, TTX should block the veratridine-induced cell
death in µHis cells (19) but not in µPore cells if µPore channels
do not bind TTX. Under the same conditions, veratridine-induced cell
death was significantly decreased in cells expressing µHis in 50 and
200 µM TTX (Fig. 5B), confirming that TTX
indeed blocked Na+ influx through µHis channels induced
by veratridine. In addition, no significant changes were observed in
control HEK293 cells (15 and 12% of cell death in 50 and 200 µM TTX, respectively). However, TTX did not reduce
veratridine-induced cell death in cells expressing µPore channels,
with cell death rates of 50 and 49% in 50 and 200 µM
TTX, respectively (Fig. 5B). Therefore, while blocking Na+ channels and antagonizing veratridine-induced cell
death in µHis cells, TTX failed to block veratridine-induced cell
death in µPore cells. Taken together, the findings were consistent
with the idea that µPore channels retain veratridine sensitivity but
lose the ability to bind TTX and STX. To obtain additional independent evidence for a toxin-recruitable ionophore, we measured intracellular Na+ in cells expressing µHis and µPore channels.
Toxin-induced Na+ Influx--
If a µPore channel
forms a veratridine-recruitable ionophore, one would expect an acute
increase of Na+ influx when µPore is activated by
veratridine. When veratridine alone was applied to cells expressing
µPore channels, there was no consistent activation of
Na+-selective currents in patch clamp recordings
(data not shown), perhaps due to the small density and time-independent
nature of the currents. The lack of TTX sensitivity also made it
impossible to use toxin sensitivity as a tool to specifically isolate
the current. Therefore, we developed an alternative strategy to assay intracellular Na+ changes in response to the opening of
channels induced by toxin treatment. CoroNa Red, a
Na+-specific fluorescent dye, exhibits sensitive responses
to Na+ concentration in the thin layer of fluid at the
surface of large airways (21). Here we used CoroNa Red Na+
indicator to measure intracellular Na+ changes generated by
Na+ influx through Na+ channels elicited by
activating toxins.
The intracellular Na+ concentration changes were detected
by changes in the CoroNa Red fluorescence using a CCD camera. These signals were normalized to the percent increase in fluorescence ( F) relative to the maximum signal after the addition of
gramicidin when intracellular and extracellular Na+ had
presumably reached equilibrium. In all experiments, gramicidin elicited
an average 2.6-fold increase over the background signal. Veratridine
alone did not induce a significant increase in F in
either µHis or µPore cells at least in the short term (over ~30
min, data not shown). Therefore, we used a combination of PbTx-3 and
veratridine to activate these channels, exploiting the fact that PbTx-3
may allosterically stimulate veratridine-induced Na+ flux.
Fig. 6A shows representative
data for µPore and µHis channels with summary plots shown in Fig.
6B. In control HEK293 cells, PbTx-3 and veratridine only
generate an average of a 2.5% increase in F (Fig.
6B). In cells expressing either µHis or µPore channels, addition of the mixture of PbTx-3 and veratridine elicited a
F increase of 35 and 31%, respectively, suggesting that
there was a significant increase of intracellular Na+ due
to Na+ influx through toxin-activated µHis or µPore
channels. Furthermore, preincubation of 1 µM TTX
significantly decreased F in µHis cells but not in
µPore cells. Thus, PbTx-3 and veratridine activated both µPore and
µHis channels and resulted in Na+ influx through the
activated channel pore. The Na+ influx in activated µPore
channels is resistant to block by TTX, further confirming the
insensitivity of µPore channels to TTX.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
Toxins induced Na+ influx.
A, representative experiments of the percent change in
fluorescence in HEK293 cells loaded with CoroNa Red expressing µ1His
and µPore channels when exposed to different toxins. B,
summary data plotting the change in fluorescence when cells were
exposed to 112 nM PbTx-3 and 150 µM
veratridine with or without preincubation of 1 µM TTX
(n = 4; regions of interest > 25; *,
p < 0.001).
|
|
 |
DISCUSSION |
In a quest for a "minimal" Na+ channel structure,
we trimmed the channels of all but those core segments that would be
absolutely required for permeation. Based on the structure of KcsA and
other Kir family K+ channels, we reasoned that the S5-P-S6
segments of a voltage-dependent Na+ channel
might retain some aspects of a functional pore. Through biochemical and
physiological characterizations, we found that S5-P-S6 segments of µ1
channels do form functional ionophores, albeit ones that lack full
fidelity when compared with the parent channels. Key structural motifs
of Na+ channels are missing in µPore channels in that
they fail to bind TTX or STX functionally and biochemically.
Nevertheless, µPore ionophores can be activated by the
Na+ channel toxins veratridine and PbTx-3 as gauged by
Na+ fluorescence measurements and cell viability assays.
The following considerations support the notion that the fluorescence
increases induced by PbTx-3 reflect the stimulation of Na+
influx through Na+ channels. First, in situ
calibration curves (not shown) indicated that CoroNa Red can track
sodium very specifically regardless of whether the remaining salt in
the solution is N-methyl-D-glucamine chloride or
KCl. Second, we also have excluded potassium as a measurable
interfering cation from examination of the in situ calibration curves that show that CoroNa Red fluorescence
decreases in the presence of high K+
concentrations (NaCl/KCl buffers) as compared with the values obtained
in the absence of K+ at the same Na+
concentration (i.e. in
NaCl/N-methyl-D-glucamine buffers). Due to the
dye structure, the coordination of negative ions should be excluded
from the crown moiety that coordinates sodium. The same would be the
case for divalent cations, although there could be some competition as
CoroNa Red is derived from EDTA-like moieties. Third, the fluxes
were only seen when PbTx-3 was added to cells expressing
Na+ channels. The signals were not observed after high
K+ depolarization of HEK293 cells expressing
Na+ channels or in control HEK cells with any of the
treatments. The fluxes were also detected when cells expressing
Na+ channels were exposed simultaneously to PbTx-3 and
veratridine dissolved in a 45 mM K+
buffer, but they were similar to those in PbTx-3 and veratridine in a normal low K+ buffer for both µpore and µHis
cells. This treatment did not induce a fluorescence increase in control
HEK293 cells, indicating that, during toxin activation, the fluxes are
not affected in a measurable way by changes in the electrochemical
gradient for potassium. If K+ efflux were to co-exist in
µPore but not in µHis cells, a measurable difference would have
been expected in the fluorescence changes. Finally, during toxin
activation in normal 140 mM Na+ buffer,
potassium would be leaking out, and therefore the proportion of
K+-dye complexes should, if anything, decrease, producing a
decrease in F if K+ were indeed a serious
contaminant. For these reasons, we believe that the toxin-activated
fluorescence signals reflect Na+ flux through
Na+ channels.
Gating of the µPore Channel--
The pore of Na+
channels exhibits a high degree of conformational flexibility and is
involved in channel gating. The domain III-IV linker of
Na+ channels is a prime determinant of rapid inactivation
(7, 22, 23), while the external pore has been linked to slow
inactivation (24-26). We hypothesized that the inactivation mechanisms
should be preserved in µPore channels as these structural elements
are still intact. Indeed, like wild-type Na+ channels,
µPore channels predominately are in closed or inactivated conformations at rest; otherwise, persistent Na+ influx at
rest might be expected to kill cells expressing µPore. Since the
voltage sensor is not present, µPore channels cannot be activated by
depolarization. However, non-voltage-dependent activation
appears to exist in µPore channels. Our results indicate that µPore
channels can be activated by Na+ channel-opening toxins.
Veratridine and PbTx-3 Mechanisms--
Veratridine and PbTx-3 are
Na+ channel openers that bind to site 2 and site 5, respectively, on the subunit of the Na+ channel (27).
Site 2 neurotoxins, including the alkaloids batrachotoxin, veratridine,
aconitine, and grayanotoxin, cause persistent activation of
Na+ channels (28, 29). Studies have shown that veratridine
and batrachotoxin share a common binding site in
DI-S6 and DIV-S6 (30, 31). In wild-type
channels, veratridine binds to open Na+ channels (32),
blocking inactivation, shifting the voltage dependence of activation to
more negative membrane potentials, and reducing selectivity. TTX and
STX potently counteract the action of veratridine. Site 5 toxins
brevotoxin and PbTx-3, lipid-soluble polyethers, bind to a receptor
site located near the transmembrane interface between DI and
DIV near the extracellular side of the DIV-S5 segment and the extracellular end of the
DI-S6 segment of the subunit (33, 34). This interaction
causes a shift in the voltage dependence of channel activation to more
negative potentials and inhibits channel inactivation. In addition, the oxygen-rich nature of the brevotoxin backbone interacts with the channel in a manner that stabilizes the open configuration (35). Moreover, site 2 and site 5 lipid-soluble toxins are allosteric modulators of channel function. PbTx-3 allosterically stimulates Na+ influx generated by site 2 toxins including veratridine
and batrachotoxin (36, 37). As segments S5 and S6 are preserved in the
µPore construct, the binding sites of veratridine and PbTx-3 might
still be intact on µPore channels. Our functional data showed that
the interactions of veratridine and PbTx-3 on µPore channel resulted in activation of the ionophore in a non-voltage-dependent fashion.
Conclusions--
In an effort to define the minimal structure
required to create a functional Na+ channel pore, we have
found that the S5-P-S6 segments of the µ1 Na+ channel
suffice to form a toxin-activable ionophore. Unfortunately, the reduced
construct does not provide a compelling platform for further protein
purification and structure prediction as it does not retain key
biochemical markers (viz. STX binding) that would enable
tracking of the protein during enrichment and purification. Nevertheless, our observations are conceptually valuable as they identify the minimal determinants for two key features of pore function
(Na+ flux and toxin activation).
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant RO1 HL52768 (to E. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of the Michel Mirowski Fellowship from the National
Association of Pacing and Electrophysiology (NASPE).
¶
The Michel Mirowski, M.D. Professor of Cardiology of The Johns
Hopkins University. To whom correspondence should be addressed: Inst.
of Molecular Cardiobiology, The Johns Hopkins University School of
Medicine, 720 N. Rutland Ave./Ross 844, Baltimore, MD 21205. Tel.:
410-955-2776; Fax: 410-955-7953; E-mail: marban@jhmi.edu.
Published, JBC Papers in Press, April 24, 2002, DOI 10.1074/jbc.M111862200
 |
ABBREVIATIONS |
The abbreviations used are:
D, domain;
S, segment;
P, pore-lining;
TTX, tetrodotoxin;
STX, saxitoxin;
PbTx-3, pumiliotoxin;
MOPS, 4-morpholinepropanesulfonic acid;
HEK, human
embryonic kidney;
IRES, internal ribosomal entry
site.
 |
REFERENCES |
| 1.
|
Hille, B.
(1992)
Ionic Channels of Excitable Membranes
, 2nd Ed.
, Sinauer Associates, Sunderland, MA
|
| 2.
|
Marbán, E.,
Yamagishi, T.,
and Tomaselli, G. F.
(1998)
J. Physiol
508,
647-657[Abstract/Free Full Text]
|
| 3.
|
Armstrong, C. M.,
and Hille, B.
(1998)
Neuron
20,
371-380[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Catterall, W. A.
(2000)
Neuron
26,
13-25[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Fozzard, H.,
and Hanck, D.
(1996)
Physiol. Rev
76,
887-926[Abstract/Free Full Text]
|
| 6.
|
Noda, M.,
Shimizu, S.,
Tanabe, T.,
Takai, T.,
Kayano, T.,
Ikeda, T.,
Takahashi, H.,
Nakayama, H.,
Kanaoka, Y.,
Minamino, N.,
Kangawa, K.,
Matsuo, H.,
Raftery, M.,
Hirose, T.,
Inayama, S.,
Hayashida, H.,
Miyata, T.,
and Numa, S.
(1984)
Nature
312,
121-127[Medline]
[Order article via Infotrieve]
|
| 7.
|
Stühmer, W.,
Conti, F.,
Suzuki, H.,
Wang, X. D.,
Noda, M.,
Yahagi, N.,
Kubo, H.,
and Numa, S.
(1989)
Nature
339,
597-603[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Doyle, D. A.,
Cabral, J. M.,
Pfuetzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and MacKinnon, R.
(1998)
Science
280,
69-77[Abstract/Free Full Text]
|
| 9.
|
Chen, Z.,
Ong, B. H.,
Kambouris, N. G.,
Marbán, E.,
Tomaselli, G. F.,
and Balser, J. R.
(2000)
J. Physiol.
524,
37-49[Abstract/Free Full Text]
|
| 10.
|
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275[Free Full Text]
|
| 11.
|
Velez, P.,
Sierralta, J.,
Alcayaga, C.,
Fonseca, M.,
Loyola, H.,
Johns, D. C.,
Tomaselli, G. F.,
Marbán, E.,
and Suárez-Isla, B. A.
(2001)
Toxicon
39,
929-935[Medline]
[Order article via Infotrieve]
|
| 12.
|
Satin, J.,
Kyle, J. W.,
Chen, M.,
Bell, P.,
Cribbs, L. L.,
Fozzard, H. A.,
and Rogart, R. B.
(1992)
Science
256,
1202-1205[Abstract/Free Full Text]
|
| 13.
|
Backx, P. H.,
Yue, D. T.,
Lawrence, J. H.,
Marbán, E.,
and Tomaselli, G. F
(1992)
Science
257,
248-251[Abstract/Free Full Text]
|
| 14.
|
Chiamvimonvat, N.,
Perez-Garcia, M. T.,
Ranjan, R.,
Marbán, E.,
and Tomaselli, G. F.
(1996)
Neuron
16,
1037-1047[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Lipkind, G.,
and Fozzard, H. A
(1994)
Biophys. J
66,
1-13[Medline]
[Order article via Infotrieve]
|
| 16.
|
Terlau, H.,
Heinemann, S. H.,
Stühmer, W.,
Pusch, M.,
Conti, F.,
Imoto, K.,
and Numa, S.
(1991)
FEBS Lett
293,
93-96[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Yotsu-Yamashita, M.,
Nishimori, K.,
Nitanai, Y.,
Isemura, M.,
Sugimoto, A.,
and Yasumoto, T.
(2000)
Biochem. Biophys. Res. Commun.
267,
403-412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Doyle, D. D.,
Guo, Y.,
Lustig, S. L.,
Satin, J.,
Rogart, R. B.,
and Fozzard, H. A.
(1993)
J. Gen. Physiol
101,
153-182[Abstract/Free Full Text]
|
| 19.
|
Takahashi, S.,
Shibata, M.,
and Fukuuchi, Y.
(1999)
Eur. J. Pharmacol
372,
297-304[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Takahashi, S.,
Shibata, M.,
Gotoh, J.,
and Fukuuchi, Y.
(2000)
Eur. J. Pharmacol.
408,
127-135[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Jayaraman, S.,
Song, Y.,
Vetrivel, L.,
Shankar, L.,
and Verkman, A. S.
(2001)
J. Clin. Investig.
107,
317-324[Medline]
[Order article via Infotrieve]
|
| 22.
|
Moorman, J. R.,
Kirsch, G. E.,
Brown, A. M.,
and Joho, R. H.
(1990)
Science
250,
688-691[Abstract/Free Full Text]
|
| 23.
|
West, J.,
Patton, D. E.,
Scheuer, T.,
Wang, Y.,
Goldin, A. L.,
and Catterall, W. A.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
10910-10914[Abstract/Free Full Text]
|
| 24.
|
Tomaselli, G. F.,
Chiamvimonvat, N.,
Nuss, H. B.,
Balser, J. R.,
Perez-Garcia, M. T., Xu, R. H.,
Orias, D. W.,
Backx, P. H.,
and Marbán, E.
(1995)
Biophys. J
68,
1814-1827[Medline]
[Order article via Infotrieve]
|
| 25.
|
Balser, J. R.,
Nuss, H. B.,
Chiamvimonvat, N.,
Perez-Garcia, M. T.,
Marbán, E.,
and Tomaselli, G. F.
(1996)
J. Physiol
494,
431-442[Abstract/Free Full Text]
|
| 26.
|
Benitah, J. P.,
Chen, Z.,
Balser, J. R.,
Tomaselli, G. F.,
and Marbán, E.
(1999)
J. Neurosci
19,
1577-1585[Abstract/Free Full Text]
|
| 27.
|
Catterall, W. A.
(1980)
Annu. Rev. Pharmacol. Toxicol
20,
15-43[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Khodorov, B. I.
(1985)
Prog. Biophys. Mol. Biol
45,
57-148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Sutro, J. B.
(1986)
J. Gen. Physiol
87,
1-24[Abstract/Free Full Text]
|
| 30.
|
Linford, N. J.,
Cantrell, A. R., Qu, Y.,
Scheuer, T.,
and Catterall, W. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
13947-13952[Abstract/Free Full Text]
|
| 31.
|
Wang, S. Y.,
and Wang, G. K.
(1999)
Biophys. J
76,
3141-3149[Medline]
[Order article via Infotrieve]
|
| 32.
|
Barnes, S.,
and Hille, B.
(1988)
J. Gen. Physiol
91,
421-443[Abstract/Free Full Text]
|
| 33.
|
Trainer, V. L.,
Thomsen, W. J.,
Catterall, W. A.,
and Baden, D. G.
(1991)
Mol. Pharmacol
40,
988-994[Abstract]
|
| 34.
|
Trainer, V. L.,
Baden, D. G.,
and Catterall, W. A.
(1994)
J. Biol. Chem
269,
19904-19909[Abstract/Free Full Text]
|
| 35.
|
Jeglitsch, G.,
Rein, K.,
Baden, D. G.,
and Adams, D. J.
(1998)
J. Pharmacol. Exp. Ther
284,
516-525[Abstract/Free Full Text]
|
| 36.
|
Sharkey, R. G.,
Jover, E.,
Couraud, F.,
Baden, D. G.,
and Catterall, W. A.
(1987)
Mol. Pharmacol
31,
273-278[Abstract]
|
| 37.
|
Wada, A.,
Uezono, Y.,
Arita, M.,
Yuhi, T.,
Kobayashi, H.,
Yanagihara, N.,
and Izumi, F.
(1992)
J. Pharmacol. Exp. Ther
263,
1347-1351[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Korff, L. Laux, K. Kelley, J. Goldstein, S. Koh, and D. Nordli Jr
Dravet Syndrome (Severe Myoclonic Epilepsy in Infancy): A Retrospective Study of 16 Patients
J Child Neurol,
February 1, 2007;
22(2):
185 - 194.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kanai, S. Hirose, H. Oguni, G. Fukuma, Y. Shirasaka, T. Miyajima, K. Wada, H. Iwasa, S. Yasumoto, M. Matsuo, et al.
Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity
Neurology,
July 27, 2004;
63(2):
329 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. B. Cronin, A. O'Reilly, H. Duclohier, and B. A. Wallace
Binding of the Anticonvulsant Drug Lamotrigine and the Neurotoxin Batrachotoxin to Voltage-gated Sodium Channels Induces Conformational Changes Associated with Block and Steady-state Activation
J. Biol. Chem.,
March 14, 2003;
278(12):
10675 - 10682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yue, B. Navarro, D. Ren, A. Ramos, and D. E. Clapham
The Cation Selectivity Filter of the Bacterial Sodium Channel, NaChBac
J. Gen. Physiol.,
November 25, 2002;
120(6):
845 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|